|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 209/80 | (2006.01) |
| A61K 31/403 | (2006.01) | ||
| A61P 43/00 | (2006.01) | ||
| C07D 209/88 | (2006.01) |
| (11) | Number of the document | 2045241 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08105552.7 |
| Date of filing the European patent application | 2003-01-22 | |
| (97) | Date of publication of the European application | 2009-04-08 |
| (45) | Date of publication and mention of the grant of the patent | 2012-07-04 |
| (46) | Date of publication of the claims translation | 2012-11-26 |
| (30) | Number | Date | Country code |
| 351384 P | 2002-01-24 | US |
| (72) |
Berthelette, Carl, CA
Lachance, Nicolas, CA
Li, Lianhai, CA
Sturino, Claudio, CA
Wang, Zhaoyin, CA
|
| (73) |
Merck Canada Inc.,
16711 Trans-Canada Highway, Kirkland, QC H94 3L1,
CA
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Fluoru pakeisti cikloalkanindolai ir jų, kaip prostaglandino D2 receptorių antagonistų, panaudojimas |
| Fluoro substituted cycloalkanoindoles and their use as prostaglandin D2 receptor antagonists |
| Payment date | Validity (years) | Amount | |
| 2013-01-10 | 11 | 1000.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2014-01-22 |